Back to Journals » Clinical and Experimental Gastroenterology » Volume 11

Short-course therapy for diarrhea-predominant irritable bowel syndrome: understanding the mechanism, impact on gut microbiota, and safety and tolerability of rifaximin

Total article views   HTML views PDF downloads Totals
30,600 Dovepress* 27,485+ 1,332 28,817
PubMed Central* 3,115 666 3,781
Totals 30,600 1,998 32,598
*Since 24 September 2018
Total mentioned Facebook Delicious Reddit Twitter Others
18 1 0 0 6 11

View citations on PubMed Central and Google Scholar